Zevin资产管理公司将AstraZeneca的持有量增加了14%,达到1 000万美元,因为制药公司提高了股息。 Zevin Asset Management increased its AstraZeneca holdings by 14%, to $10 million, as the drug company raised its dividend.

投资公司Zevin资产管理有限公司在第四季度将其在AstraZeneca PLC的持有量增加了14%,达到152 875股,价值10 016 000美元。 Investment firm Zevin Asset Management LLC increased its holdings in AstraZeneca PLC by 14% in the fourth quarter, to 152,875 shares, worth $10,016,000. AstraZeneca是一家生物制药公司,市场上限为2 400.65亿美元,最近宣布半年红利为1.03美元,比2月21日的4.49美元上调。 AstraZeneca, a biopharmaceutical company, has a market cap of $240.65 billion and recently announced a semi-annual dividend of $1.03, up from $0.49, for shareholders of record on Feb. 21. 该公司的产品包括心血管、肾脏、新陈代谢和肿瘤学药品。 The company's products include drugs for cardiovascular, renal, metabolism, and oncology.